Company Profile

Cervimark LLC (AKA: Jodie Rai MD)
Profile last edited on: 1/27/2011      CAGE: 4GM78      UEI: ----------

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2004
First Award
2007
Latest Award
2007
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1034 South Brentwood Boulevard Suite 910
Saint Louis, MO 63117
   (314) 721-4707
   jodierai@earthlink.net
   N/A
Location: Single
Congr. District: 01
County: St. Louis

Public Profile

Cervimark LLC have developed a way to identify biomarkers that are a factor in preterm births. Cervimark's next step: a clinical trial that will enroll 200 to 300 pregnant mothers who could be at risk for preterm delivery. That test phase should take another six months to a year. If the results continue to be positive, Cervimark expects to apply for an NIH grant of $1 million for a larger study before taking any test to market. The test is not a treatment. At-risk patients could use the results to take steps to minimize the danger of a preterm birth, such as relocating from a rural area closer to medical facilities that can handle the condition or modifying their lifestyle. Based on the results, doctors also could recommend additional medical treatments.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 1 NIH $105,395
Project Title: Cervical biomarkers of preterm delivery

Key People / Management

  Jodie Rai -- President

  Robert Kokenyesi

Company News

There are no news available.